Topoisomerase IIβ Kinase: A protein processed from HIV-1 envelope by cysteine proteases

Topoisomerase IIβ (TopoIIβ) is activated by TopoIIβ kinase (TopoIIβK) during HIV-1 infection. This study demonstrates that TopoIIβK is produced within 15-30 minutes post-infection and is conserved across the major HIV-1 subtypes (A, B, C, and D), although its formation kinetics vary among subtypes. Immunological mapping using specific anti-gp120 antibodies suggests that TopoIIβK is derived from the N-terminal region of gp120. Notably, TopoIIβK co-localizes with endolysosomes shortly after viral entry. Inhibition of cysteine proteases using E64d and Z-FY-CHO abrogates TopoIIβK production in both HIV-1-infected and envelope-transfected cells. These findings suggest that TopoIIβK is a conserved polypeptide product of gp120 processing within endolysosomes during the early stages of HIV-1 infection, highlighting a potentially conserved mechanism that regulates early viral infection across major HIV-1 subtypes.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-10-28
DOI
https://doi.org/10.64898/2026.10.26.761857
Primary Topic
HIV Research and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Topoisomerase IIβ Kinase: A protein processed from HIV-1 envelope by cysteine proteases

Satyajit Mukhopadhyay, Anand Kumar Kondapi, Sangeetha Balasubramanian, Ritika Das et al.
bioRxiv (Cold Spring Harbor Laboratory)
HIV Research and Treatment
preprint

Topoisomerase IIβ Kinase: A protein processed from HIV-1 envelope by cysteine proteases

Satyajit Mukhopadhyay, Anand Kumar Kondapi, Sangeetha Balasubramanian, Ritika Das, Hema Verma, Abhash Kumar, Balakrishna S Lokeswara
preprint en

Abstract

Topoisomerase IIβ (TopoIIβ) is activated by TopoIIβ kinase (TopoIIβK) during HIV-1 infection. This study demonstrates that TopoIIβK is produced within 15-30 minutes post-infection and is conserved across the major HIV-1 subtypes (A, B, C, and D), although its formation kinetics vary among subtypes. Immunological mapping using specific anti-gp120 antibodies suggests that TopoIIβK is derived from the N-terminal region of gp120. Notably, TopoIIβK co-localizes with endolysosomes shortly after viral entry. Inhibition of cysteine proteases using E64d and Z-FY-CHO abrogates TopoIIβK production in both HIV-1-infected and envelope-transfected cells. These findings suggest that TopoIIβK is a conserved polypeptide product of gp120 processing within endolysosomes during the early stages of HIV-1 infection, highlighting a potentially conserved mechanism that regulates early viral infection across major HIV-1 subtypes.

bioRxiv (Cold Spring Harbor Laboratory)
University of Hyderabad (IN)
Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Topoisomerase IIβ Kinase: A protein processed from HIV-1 envelope by cysteine proteases — Satyajit Mukhopadhyay, Anand Kumar Kondapi, et al. · bioRxiv (Cold Spring Harbor Laboratory) (2026) | TGRS Research Map | TGRS